National Drug Abuse Treatment



Protocols (Studies) in the CTN

Number Name
Status
CTN-0001

Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification

completed
CTN-0002

Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

completed
CTN-0003

Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules

completed
CTN-0004

MET (Motivational Enhancement Treatment) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

completed
CTN-0005

MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

completed
CTN-0006

Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics

completed
CTN-0007

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

completed
 
CTN-0007-A-1
Survey of Counselor's Perceptions of Incentive Programs
completed
 
CTN-0007-A-2
Economic Evaluations in the CTN -- Methods & Applications
completed
CTN-0008

Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

completed
CTN-0009

Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs

completed
CTN-0010

Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults

completed
 
CTN-0010-A-1
Cost-Effective Analysis (CEA) in the CTN: Bup/Nal Treatment for Opioid Addicted Youth
completed
 
CTN-0010-A-2
Comorbid Conditions in Adolescents with Opioid versus Alcohol/Marijuana Use Disorders
completed
CTN-0011

A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities

completed
CTN-0012

Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

completed
CTN-0013

Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users

completed
 
CTN-0013-A-1
Trauma and Intravenous Drug Use among Pregnant Alcohol/Other Drug Abusing Women: Factors in Predicting Child Abuse Potential
completed
CTN-0014

Brief Strategic Family Therapy for Adolescent Drug Abusers

completed
 
CTN-0014-A-1
Mediators and Moderators of BSFT for Adolescent Drug Use
completed
CTN-0015

Women's Treatment for Trauma and Substance Use Disorders

completed
 
CTN-0015-A-1
Survey of Eating Disorder Symptoms among Women in Treatment for Substance Abuse Disorders
completed
CTN-0016

Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Settings

completed
CTN-0017

HIV and HCV Intervention in Drug Treatment Settings

completed
CTN-0018

Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment

completed
CTN-0019

Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment

completed
CTN-0020

Job Seekers Training for Patients with Drug Dependence

completed
 
CTN-0020-A-1
Job Seekers' Training for Clients/Relatives with Drug Dependence (Specific to the Na'Nizhoozhi Center, Inc.)
completed
CTN-0021

Motivational Enhancement Treatment to Improve Treatment Engagement and Outcomes for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse

completed
CTN-0027

Starting Treatment with Agonist Replacement Therapies (START)

completed
 
CTN-0027-A-1
START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
active
 
CTN-0027-A-2
Retention of Suboxone Patients in START: Perspectives of Providers and Patients
active
CTN-0028

Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders

completed
 
CTN-0028-A-1
Does Methylphenidate Treatment for ADHD Increase the Rate of Smoking in Adolescents with Comorbid ADHD, Substance Use Disorder, and Nicotine Dependence?
active
CTN-0029

A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD

completed
CTN-0030

Prescription Opioid Addiction Treatment Study (POATS)

completed
 
CTN-0030-A-1
Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
active
 
CTN-0030-A-2
Effects of Chronic Opioids on the Brain
active
 
CTN-0030-A-3
Protocol Amendment to Examine Long-Term Outcomes
active
CTN-0031

Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

completed
 
CTN-0031-A-1
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Ancillary Investigation
active
 
CTN-0031-A-2
The Role of Alcohol Consumption in Classifications of Alcohol Use Disorders: A Clinical Study
active
 
CTN-0031-A-3
Organizational Characteristics that Influence the Adoption of Evidence-Based Practices
active
CTN-0032 HIV Rapid Testing and Counseling
completed
 
CTN-0032-A-1
Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
active
CTN-0033-Ot Methamphetamine Use Among American Indians  
 
CTN-0033-Ot-1
Methamphetamine Use Among American Indians
active
 
CTN-0033-Ot-2
Methamphetamine Use and Treatment in Native American Communities in the Southwest
active
 
CTN-0033-Ot-3
Methamphetamine: Where Does It Fit in the Bigger Picture of Drug Use of American Indian and Alaska Native Communities and Treatment Seekers?
active
 
CTN-0033-Ot-4
An Exploration of Methamphetamine and Other Drug Use and Treatment Options Among Urban and Rural Northern Plains American Indians
active
 
CTN-0033-Ot-5
The Choctaw Nation Methamphetamine Data Needs Project
active
CTN-0034-Ot Developing Research Capacity and Culturally Appropriate Research Methods: Community-Based Participatory Research Manual for Collaborative Research in Drug Abuse for American Indians and Alaska Natives
active
CTN-0035-Ot Access to HIV and Hepatitis Screening and Care Among Ethnic Minority Drug Users In and Out of Drug Treatment
active
CTN-0036-Ot Epidemiology and Ethnographic Survey of "Cheese" Heroin Use among Hispanics in Dallas County
completed
CTN-0037 Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
active
CTN-0038 Ot Barriers to Substance Abuse Treatment Among Asian Americans and Pacific Islanders
active
CTN-0039-S Gender Differences in the Prevalence and Predictors of HIV Risk Behaviors
active
CTN-0040-S Pattern of Alcohol Use and Alcohol-Related Diagnoses among Drug Abusing/Dependent Participants
active
CTN-0041-S Relationships Between Demographic Characteristics of Patients and Therapists, Measures of Therapeutic Process and Therapeutic Alliance, and Outcomes
active
CTN-0042-S Efficacy of Motivational Enhancement Therapy for African Americans
active
CTN-0043-S Substance Abuse Treatment Outcomes in Racial/Ethnic Minority Populations
active
CTN-0044 Web Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
active
  CTN-0044-A-2 Acceptability of a Web-Delivered, Evidence-Based, Psychosocial Intervention Among Individuals with Substance Use Disorderrs Who Identify as American Indian/Alaska Native
active
CTN-0045-Ot Rates of HIV Testing and Barriers to Testing in African Americans Receiving Substance Abuse Treatment
active
CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence
active
  CTN-0046-A-1 Site Influences on Treatment Effects - Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant-Dependence Outcome
active
CTN-0047 Screening Motivational Assessment and Referral to Treatment in Emergency Departments (SMART-ED): Evaluation of Screening, Brief Intervention, Referral to Treatment (SBIRT) and Booster Session for Drug Use Patients Presenting for Treatment in the Emergency Department
active
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
active
     
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2010 -- http://ctndisseminationlibrary.org/protocols.htm
info@ctndisseminationlibrary.org